General Archive
-
News releasesPACE announces £6 million funding for antibacterial treatment innovations to fill critical gap in R&D pipeline
PACE (Pathways to Antimicrobial Clinical Efficacy) launches its third funding round today, supporting innovative projects that tackle resistant bacterial infections…
-
BlogsEmbracing innovation: CAR T-cells and childhood cancer
For Childhood Cancer Awareness Month, we reflected on some of the challenges and opportunities in childhood cancer research. Here, David…
-
News releasesC-Further announces major partnership with GOSH Charity to drive innovation in childhood cancer treatment
Great Ormond Street Hospital Charity (GOSH Charity), the UK’s largest dedicated charitable funder of child health research, has joined us…
-
BlogsOpening doors to data science: The HDR UK Black Internship Programme
This July, as part of Health Data Research UK’s (HDR UK) Black Internship Programme, our data science team welcomed Varaidzo…
-
ArticlesLifeArc Pathfinder Award recipients uncover genetic cause of severe nerve condition in children
Researchers at the University of Manchester have identified a rare genetic mutation that causes severe nerve damage in children following mild infections. Their findings…
-
ArticlesLifeArc and Genetic Alliance UK launch a new report calling for the acceleration of research and development (R&D) for rare diseases
LifeArc and Genetic Alliance UK have launched a report calling for the UK Government, NHS, researchers, industry, patient groups and…
-
ArticlesLifeArc joins new global initiative to accelerate drug discovery for ALS/MND treatments
LifeArc joins new global initiative to accelerate drug discovery for ALS/MND treatments LifeArc has become a partner of the Longitude…
-
ArticlesLifeArc appoints new General Counsel and Company Secretary and Chief Communications Officer
We have appointed two new members to our executive team: Jan Lasik as our new General Counsel and Company Secretary,…
-
ArticlesLifeArc supports research to develop a quick, affordable blood test for the early detection of dementia
As part of a collaboration with UK Dementia Research Institute, we are supporting research to validate a new blood test…
-
News releasesTribune Therapeutics raises EUR 37 million for next-generation anti-fibrotic therapies
Tribune Therapeutics AB, a biotechnology company dedicated to treating the root causes of fibrotic diseases, today announced it has raised…
-
News releasesHillstar Bio closes $67 million Series A financing round
Hillstar Bio, a leading biotechnology company focused on developing next-generation precision immunology therapies for autoimmune diseases, today announced the successful…
-
News releasesLifeArc invests in Maxion Therapeutics Series A
Maxion Therapeutics (“Maxion”), a biotechnology company developing antibody-based KnotBody® drugs for ion channel- and G protein coupled receptor (GPCR)-driven diseases,…